Bambusa Therapeutics has raised about $90 million to build out a pipeline of next-gen bispecific antibodies targeting ...

Boston biotech Kojin Therapeutics is closing its doors, citing four funding challenges and a few valuable lessons learned.  ...

In his next chief executive gig after securing the $14 billion acquisition of Karuna Therapeutics Inc., Bill Meury has now ...

News of the layoffs come just one day after the company reported a 5% year over year revenue increase — boosting revenue to ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

The first local company to reach "unicorn" status in 2025 isn't a tech startup, unlike most of the "unicorns" Greater Boston ...

Of the 102 company launches or series A financings since October 2023, just nine had a woman at the helm, according to a ...

Access to data and to skills specific to AI are among the key challenges pharma companies face to unlock the technology’s ...

Rare diseases have become an attractive target for pharmaceutical companies both in Australia and internationally with ...

Fresh from FDA approval for its paediatric stem-cell product, Mesoblast is pursuing consent for indications of heart disease ...

The Crimson spoke to a range of commercial realtors, startup founders, and a commercial lab space owner to understand how the immense draw of Kendall Square has forced the myriad startup companies ...

His Majesty King Abdullah II on Monday met with CEOs of companies and heads of universities and higher education institutions in Boston, Massachusetts, to discuss means of building and enhancing ...